View Press Releases
-
Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening
-
Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models
-
Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation
-
Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant
-
Scitara announces partnership with Agilent to benefit customers with enhanced digital lab connectivity
-
Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery
Connect in Pharma provided a platform where key players in European pharma found innovative, patient-centric and sustainable solutions for strengthening the pharmaceutical supply chain.
Sep 21, 2022
-
Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service
-
Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals
-
Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins
-
Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
-
Springer Nature Joins PubHive Document Delivery Service
The newly signed document delivery distribution agreement will make Springer Nature article acquisition available to life science companies that license access to PubHive’s scientific workflow management platform
Sep 21, 2022
-
QuBAS 3.0 cuts biostatistics method development time by 80%
Upgraded biostatistics software platform from Quantics offers enhanced flexibility for optimal early-stage development.
Sep 20, 2022
-
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
-
Cresset secures significant growth funding from SEP
Cresset, a drug discovery software scaleup, has raised growth capital from SEP to accelerate its product development and international expansion.
Sep 20, 2022
-
Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology
-
Basepair™ - The Point and Click NGS Analysis & Visualization Platform Now Available in AWS Marketplace
Basepair™, The First Point and Click NGS Analysis & Visualization Platform of It's Kind is Now Available in AWS Marketplace
Sep 26, 2022
-
DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE
Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.
Sep 19, 2022
-
Curebase and Meru Health to Partner on Clinical Research for App-based Mental Health Treatment Program
Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.
Sep 19, 2022
-
VERICHEM OFFERS CLINICAL REFERENCE MATERIALS FOR THE CALIBRATION VERIFICATION TESTING OF LACTATE ASSAYS
VERICHEM LABORATORIES now offers a liquid stable and ready-to-use set of clinical reference materials for use with the clinical testing of Lactate.
Sep 18, 2022
-
Step up Research on Magnetic Metal Complexes Using Versatile Materials